Learn more

KLOSTERFRAU MCM VETRIEB GMBH

Overview
  • Total Patents
    127
  • GoodIP Patent Rank
    198,405
About

KLOSTERFRAU MCM VETRIEB GMBH has a total of 127 patent applications. Its first patent ever was published in 1940. It filed its patents most often in Germany, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, foods and drinks and organic fine chemistry are STRATEGIC SCIENCE & TECH LLC, TRITECH BIOPHARMACEUTICALS CO LTD and CELL THERAPY AND TECH S A DE C V.

Patent filings per year

Chart showing KLOSTERFRAU MCM VETRIEB GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Greve Harald 61
#2 Vestweber Anna-Maria 36
#3 Greve Harald Dr 16
#4 Miething Holger 12
#5 Ploch Michael 11
#6 Nauert Christian 10
#7 Unkauf Markus 10
#8 Greve Rainer 10
#9 Schlueter Andreas 8
#10 Duchatsch Walter 6

Latest patents

Publication Filing date Title
DE102014116903A1 Cineole-containing composition for nasal administration
DE102014016158A1 Composition for the treatment of stomach disorders
DE102014103832A1 Composition for the treatment of stomach disorders
DE102013000699A1 Pharmaceutical composition, useful for topical treatment of hoarseness/inflammatory diseases of mouth and throat, comprises virustatisches or antiviral polysaccharide, and acidic glycosaminoglycan, preferably hyaluronic acid
DE102013000700A1 Composition useful e.g. for treating inflammatory diseases of oral and pharyngeal cavity, comprises virustatic and/or antiviral polysaccharide, surface disinfectant, optionally acidic glycosaminoglycan and optionally local anesthetic
DE102013000586A1 Composition for topical application
DE102012011447A1 Use of pantothenol or its ester and/or pantothenic acid or its salts together and/or in combination with imidazoline-based alpha-sympathomimetic activity or its salts, used to treat rhinitis and/or to prepare drug for treating rhinitis
DE102012005452A1 Composition for nasal application with improved stability
DE102012001731A1 Systemic dosage forms with controlled release and improved stability
WO2012130351A1 Composition for use for digestive problems
DE102012000976A1 Composition for topical treatment
DE102012000430A1 Topical composition, useful to avoid and/or reduce scar formation, comprises onion extract and panthenol and/or its derivatives, preferably esters and/or pantothenic acid and/or its salt
DE102012000416A1 Topical composition, useful for treating wounds, preferably open wounds and ulcers, comprises fusafungine and/or one of its derivative and onion extract
DE102011122236A1 Composition useful e.g. in topical treatment of inflammatory diseases of skin and/or mucous membrane, comprises fusafungine and its derivate, and acidic glycosaminoglycan or its derivatives
DE102011122250A1 Multiphase system, useful e.g. to treat vitamin deficiency, comprises two different phases/layers comprising first phase/layer of active component comprising iron(II) compound, and second phase/layer of active component comprising vitamin
DE102011106089A1 Heat support useful e.g. for prophylactic, therapeutic treatment of pain and/or muscle tension, and/or for preferably local increase in blood flow and/or hemoperfusion comprises system and/or unit for generating heat
UA101688C2 Normal;heading 1;heading 2;heading 3;NEW APPLICATION FORM FOR CINEOLE
DE102010055170A1 Process for the preparation of non-alcoholic vegetable-based compositions and compositions prepared in this way and their use
DE102010054127A1 Process for the preparation of non-alcoholic plant-based compositions and compositions prepared in this way and their use
DE102010054128A1 Process for the preparation of alcohol-free compositions and compositions prepared in this way and their use